Bogle Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-30,173
Closed -$600K 403
2014
Q3
$600K Sell
30,173
-371,882
-92% -$7.83M 0.04% 280
2014
Q2
$9.16M Buy
402,055
+88,717
+28% +$1.58M 0.61% 72
2014
Q1
$4.03M Buy
313,338
+109,495
+54% +$1.57M 0.28% 116
2013
Q4
$2.78M Buy
203,843
+31,243
+18% +$373K 0.23% 137
2013
Q3
$1.91M Buy
+172,600
New +$1.72M 0.19% 162

Other funds holding RGEN

Bogle Investment Management's RGEN Position: Q4 2014 in Review

Bogle Investment Management sold out of Repligen (RGEN) in Q4 2014, closing a stake of 30,173 shares — an estimated $600K sold.

Bogle Investment Management first reported a position in RGEN in Q3 2013 and held it in 5 quarters. The position peaked at $9.16M in Q2 2014. 164 funds tracked by Wall St. Rank hold RGEN as of Q4 2014.

  • Bogle Investment Management reported no remaining Repligen position as of Q4 2014 after selling out during the quarter.
  • Bogle Investment Management sold 30,173 Repligen shares in Q4 2014, an estimated $600K.
  • Bogle Investment Management first reported a position in Repligen in Q3 2013 and held it in 5 quarters.
  • Bogle Investment Management's Repligen position peaked at $9.16M in Q2 2014.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q4 2014.

Based on Bogle Investment Management's 13F filing for Q4 2014, filed 13 Feb 2015.